Adaptimmune Therapeutics shares owned by Long Focus Capital Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Long Focus Capital Management
from 13F filings
Historical chart of Long Focus Capital Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Long Focus Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Long Focus Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $9.6M | 12M | 0.79 |
| 2023-09-30 | $8.6M | 11M | 0.78 |
| 2023-06-30 | $7.2M | 7.8M | 0.93 |
| 2023-03-31 | $5.9M | 5.4M | 1.09 |
| 2022-12-31 | $7.7M | 5.3M | 1.46 |
| 2022-09-30 | $5.1M | 4.8M | 1.08 |
| 2022-06-30 | $8.0M | 4.7M | 1.70 |
| 2022-03-31 | $9.1M | 4.4M | 2.06 |
| 2021-12-31 | $8.1M | 2.2M | 3.75 |
More positions owned by Long Focus Capital Management
Antero Res (AR)
View all positions for Long Focus Capital Management